A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD. Singh D, Martinez FJ, Watz H, Bengtsson T, et al. Respir Res 2020;21:47.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singh D, Martinez FJ, Watz H, Bengtsson T, et al. A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD. Respir Res 2020;21:47.
PMID: 32041601